Virios Therapeutics Future Growth
Future criteria checks 0/6
Virios Therapeutics's earnings are forecast to decline at 4.2% per annum while its annual revenue is expected to grow at 70.1% per year. EPS is expected to grow by 4.9% per annum.
Key information
-4.2%
Earnings growth rate
4.9%
EPS growth rate
| Biotechs earnings growth | 24.0% |
| Revenue growth rate | 70.1% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 06 Mar 2024 |
Recent future growth updates
Recent updates
Is Virios Therapeutics (NASDAQ:VIRI) In A Good Position To Invest In Growth?
Aug 24
Can Virios Therapeutics (NASDAQ:VIRI) Afford To Invest In Growth?
May 11Virios Therapeutics slides 11% postmarket on proposed stock offering
Sep 19Virios Therapeutics GAAP EPS of -$0.44 beats by $0.07
Aug 11Here's Why We're Watching Virios Therapeutics' (NASDAQ:VIRI) Cash Burn Situation
Jun 25Is Virios Therapeutics (NASDAQ:VIRI) In A Good Position To Invest In Growth?
Mar 09Will Virios Therapeutics (NASDAQ:VIRI) Spend Its Cash Wisely?
Nov 02Here's Why We're Not Too Worried About Virios Therapeutics' (NASDAQ:VIRI) Cash Burn Situation
Jul 19Virios Therapeutics shares rise after dosing first patient in mid-stage fibromyalgia study
Jun 04Virios Therapeutics (NASDAQ:VIRI) Is In A Good Position To Deliver On Growth Plans
Mar 31Virios Therapeutics gains 10% on research deal in irritable bowel syndrome
Feb 01Virios Therapeutics prices IPO at $10
Dec 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -17 | N/A | N/A | 1 |
| 12/31/2025 | N/A | -13 | N/A | N/A | 2 |
| 12/31/2024 | N/A | -5 | N/A | N/A | 2 |
| 12/31/2023 | N/A | -5 | -5 | -5 | N/A |
| 9/30/2023 | N/A | -6 | -6 | -6 | N/A |
| 6/30/2023 | N/A | -8 | -8 | -8 | N/A |
| 3/31/2023 | N/A | -10 | -11 | -11 | N/A |
| 12/31/2022 | N/A | -12 | -11 | -11 | N/A |
| 9/30/2022 | N/A | -15 | -14 | -14 | N/A |
| 6/30/2022 | N/A | -16 | -14 | -14 | N/A |
| 3/31/2022 | N/A | -17 | -13 | -13 | N/A |
| 12/31/2021 | N/A | -16 | -16 | -16 | N/A |
| 9/30/2021 | N/A | -18 | -13 | -13 | N/A |
| 6/30/2021 | N/A | -17 | -11 | -11 | N/A |
| 3/31/2021 | N/A | -13 | -9 | -9 | N/A |
| 12/31/2020 | N/A | -10 | -4 | -4 | N/A |
| 9/30/2020 | N/A | -4 | -2 | -2 | N/A |
| 6/30/2020 | N/A | -3 | -2 | -2 | N/A |
| 3/31/2020 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2019 | N/A | -2 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VIRI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VIRI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VIRI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VIRI is forecast to have no revenue next year.
High Growth Revenue: VIRI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VIRI's Return on Equity is forecast to be high in 3 years time